Published Jul 7, 2021
Tune in, SPAC on, drop LSD
Explore the explosive growth and transformative potential of psychedelics in mental health care, as new investments and innovations like at-home ketamine therapy and clinical management tools redefine treatment avenues amidst evolving regulatory landscapes.
Topics covered
Popular Clips
Episode Highlights
Related Episodes
Do you need a SPAC therapist?
Answers 383 questions
SPAC is a four-letter word again
Answers 383 questions
Hundreds of SPACs waiting in the woods
Answers 383 questions
SpaceX is really just SPAC and an ex
Answers 383 questionsThe new alchemy is turning gold to crypto
Answers 383 questions
You can only invest if you promise not to read the fine print, ok?
Answers 383 questionsThe SPAC trash ticker is counting down
Answers 383 questionsCES, Circle-ing back to IPOs and why we're over the moon about Overmoon
Answers 383 questionsSaaS goes to space as some software startups are in a race to survive
Answers 383 questions
Ladies and gentlemen: the dregs of the SPAC boom
Answers 383 questionsAs the economy falters, tracking the money behind the money
Answers 383 questions
It's a fintech world, and we're just living in it
Answers 383 questionsLeverage, red flags, and a changing venture landscape
Answers 383 questions
Investors are either ghosting, quiet quitting or rewriting their entire playbook
Answers 383 questions